Dubar V - Search Results

1

Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol.

Dubar V, Pascreau T, Dupont A, Dubucquoi S, Dautigny AL, Ghozlan B, Zuber B, Mellot F, Vasse M, Susen S, Poissy J, Gaudet A. Dubar V, et al. Biomedicines. 2023 May 23;11(6):1504. doi: 10.3390/biomedicines11061504. Biomedicines. 2023. PMID: 37371599 Free PMC article.

2

What applications for plasma endocan measurement in intensive care? A clarification.

Dubar V, Chenevier-Gobeaux C, Poissy J, Gaudet A. Dubar V, et al. Crit Care. 2023 Oct 17;27(1):397. doi: 10.1186/s13054-023-04686-1. Crit Care. 2023. PMID: 37848982 Free PMC article. No abstract available.

3

BMI and pneumonia outcomes in critically ill covid-19 patients: An international multicenter study.

Chetboun M, Raverdy V, Labreuche J, Simonnet A, Wallet F, Caussy C, Antonelli M, Artigas A, Goma G, Meziani F, Helms J, Mylonakis E, Levy MM, Kalligeros M, Latronico N, Piva S, Cerf C, Neuville M, Klouche K, Larcher R, Tamion F, Occhiali E, Snacken M, Preiser JC, Kontar L, Riviere A, Silva S, Sarton B, Krouchi R, Dubar V, Palaiodimos L, Karamanis D, Perche J, L'Her E, Busetto L, Dicker D, Lev S, Duhamel A, Jourdain M, Pattou F. Chetboun M, et al. Among authors: dubar v. Obesity (Silver Spring). 2021 Sep;29(9):1477-1486. doi: 10.1002/oby.23223. Obesity (Silver Spring). 2021. PMID: 33966355 Free PMC article.

4

Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic.

Annane D, Antona M, Lehmann B, Kedzia C, Chevret S; CORTIFLU Investigators; CRICs; AZUREA; REVA/SRLF networks. Annane D, et al. Intensive Care Med. 2012 Jan;38(1):29-39. doi: 10.1007/s00134-011-2409-8. Epub 2011 Nov 26. Intensive Care Med. 2012. PMID: 22120766 Clinical Trial.

5

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.

Yazdanpanah Y, Fagard C, Descamps D, Taburet AM, Colin C, Roquebert B, Katlama C, Pialoux G, Jacomet C, Piketty C, Bollens D, Molina JM, Chêne G; ANRS 139 TRIO Trial Group. Yazdanpanah Y, et al. Clin Infect Dis. 2009 Nov 1;49(9):1441-9. doi: 10.1086/630210. Clin Infect Dis. 2009. PMID: 19814627 Clinical Trial.

6

In vitro acute effects of tobacco smoke on tumor necrosis factor alpha and interleukin-6 production by alveolar macrophages.

Dubar V, Gosset P, Aerts C, Voisin C, Wallaert B, Tonnel AB. Dubar V, et al. Exp Lung Res. 1993 May-Jun;19(3):345-59. doi: 10.3109/01902149309064351. Exp Lung Res. 1993. PMID: 8319604

7

[In vivo kinetics of cotrimoxazole in alveolar macrophages].

Lopez I, Dubar V, Aerts C, Lhermitte M, Voisin C, Wallaert B. Lopez I, et al. Among authors: dubar v. Rev Mal Respir. 1991;8(1):89-94. Rev Mal Respir. 1991. PMID: 2034860 French.

8

The penetration of co-trimoxazole into alveolar macrophages and its effect on inflammatory and immunoregulatory functions.

Dubar V, Lopez I, Gosset P, Aerts C, Voisin C, Wallaert B. Dubar V, et al. J Antimicrob Chemother. 1990 Dec;26(6):791-802. doi: 10.1093/jac/26.6.791. J Antimicrob Chemother. 1990. PMID: 1964447

9

[Study of the in vivo penetration of cotrimoxazole in alveolar macrophages].

Lopez I, Dubar V, Aerts C, Voisin C, Wallaert B. Lopez I, et al. Among authors: dubar v. Pathol Biol (Paris). 1990 Apr;38(4):286-8. Pathol Biol (Paris). 1990. PMID: 2377389 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page